Acquired demyelinating diseases of the central and peripheral nervous systems comprise an important group of neurologic diseases of unknown etiology and incompletely understood pathogenesis. Cultures of glial cells are proving highly useful in investigating the role of both antibodies and cytokines in the pathogenesis of these disorders. While there clearly is need for comparative studies employing more complex systems and using patient derived tissues, glial cell cultures provide important advantages by allowing researchers to characterize the effect of cytokines and growth factors on specific cell types in controlled conditions.
1 Abramsky O, Lisak RP, Silberberg DH, Pleasure DE. (1977) Antioligodendroglia antibodies in patients with multiple sclerosis. New Engl J Med297: 1207–1211.
2.
2 Kennedy PGE, Lisak RP. (1979) A search for antibodies against glial cells in the serum and cerebrospinal fluid of patients with multiple sclerosis and Guillain-Barre syndrome. J Neurol Sci44: 125–133.
3.
3 Kennedy PGE, Lisak RP. (1981) Do patients with demyelinating diseases have antibodies against human glial cells in their sera? J Neurol Neurosurg Psychiat44: 164–167.
4.
4 Lisak RP et al. (1984) Immune responses to myelin antigens in multiple sclerosis. Ann NY Acad Sci436: 221–230.
5.
5 Lisak RP et al. (1984) Serum-mediated cell cytotoxicity in the Guillain-Barre syndrome. Neurology34: 1240–1243.
6.
6 Hirayama M, Lisak RP, Silberberg DH. (1986) Serum-mediated oligodendrocyte cytotoxicity in multiple sclerosis patients and controls. Neurology36: 276–278.
7.
7 Suzumura A, Lisak RP, Silberberg DH. (1986) Serum cytotoxicity to oligodendrocytes in multiple sclerosis and controls: Assessment by 51Cr release assay. J Neuroimmunol11: 137–147.
8.
8 Abramsky O, Lisak RP, Silberberg DH, Pleasure D. (1979) Immune responses to isolated oligodendrocytes. J Neuro J Sci43: 157–167.
9.
9 Lisak RP et al. (1980) EAE, EAN, and anti-galactocerebroside sera bind to oligodendrocytes and Schwann cells. J Neurol Sci48: 287–296.
10.
10 Armati-Gulson PJ, Lisak RP, Kuchmy D, Pollard J. (1983) 51Cr release cytotoxicity radioimmunoassay to rat Schwann cell in vitro. Neurosci Lett35: 312–326.
11.
11 Lisak RP. (1988) Glial cells and products of activated inflammatory cells: Implications for pathogenesis and treatment of multiple sclerosis. In: Cuzzullo CL, Caputo D, Ghezzi A, Zaffaroni M (eds.) Virology and Immunology in Multiple Sclerosis: rationale for therapy.Springer-Verlag, Heidelberg pp 13–20.
12.
12 Merrill JR. (1989) Effect of lymphokines and monokines on glial cells in vitro and in vivo. In: Neuroimmune Networks: Physiology and Diseases.Alan R Liss, New York, pp 89–97.
13.
13 Lisak RP. (1989) Cytokine-Schwann cell interactions. In: Scarpini E, Fiori M, Pleasure D, Scarlato G (eds.) Peripheral Nerve Development and Regeneration, Recent Advances and Clinical Applications, Fidia Research Series, Vol 19, Liviana Press: Padova pp 93–101.
14.
14 Zweiman B, Lisak RP. (1986) Lymphocyte phenotypes in the MS lesion. What do they mean? Ann Neurol19: 588–589.
15.
15 Neumann H, Cavalie A, Jenne DE, Wekerle H. (1995) Induction of MHC class I genes in neurons. Science269: 549–552.
16.
16 Prineas JW. (1985) The neuropathology of multiple sclerosis. In: Koetsier JC (volume editor), Vinken PJ, Bruyn GW, Klawans HL (series eds) Handbook of Clinical Neurology, Demyelinating Diseases, Revised series 3, Vol 47, Elsevier: Amsterdam pp 213–258.
17.
17 Fontana A, Greider A, Arrenbrecht ST, Grob P. (1980) In vitro stimulation of glial cells by a lymphocyte-produced factor. J Neurol Sci46: 55–62.
18.
18 Fontana A, Fierz W, Wekerle H. (1984) Astrocytes present myelin basic protein to encephalitogenic T-cell lines. Nature307: 276.
19.
19 Fontana A et al. (1982) Production of prostaglandin E and interleukin-1 like factors by cultured astrocytes and C-6 glioma cells. J Immunol129: 2413–2419.
20.
20 Fontana A, Grob PJ. (1984) Lymphokines and the brain. Spring Seminar Immunopathol6: 375–386.
21.
21 Lisak RP et al. (1985) Products of activated lymphocytes induce Schwann cell mitosis in vitro. Neurosci Lett57: 105–111.
22.
22 Benveniste EN, Merrill JE. (1986) Stimulation of oligodendroglial proliferation and maturation by interleukin-2. Nature321: 610–613.
23.
23 Saneto RP et al. (1986) Interleukin 2 mediates the inhibition of oligodendrocyte progenitor cell proliferation in vitro. Proc Natl Acad Sci USA83: 9221–9225.
24.
24 Saneto RP, Chiappelli F, de Vellis J. (1987) Interleukin-2 inhibition of oligodendrocyte progenitor cell proliferation depends on expression of the TAC receptor. J Neurosci Res18: 147–154.
25.
25 Suzumura A, Lisak RP, Silberberg DH. (1986) The expression of MHC antigens on oligodendrocytes: Induction of polymorphic H-2 expression by lymphokines. J Neuroimmunol11: 179–190.
26.
26 Giulian D, Lachman LB. (1985) Interleukin-1 stimulation of astroglial proliferation after brain injury. Science228: 497–499.
27.
27 Heumann R et al. (1987) Differential regulation of mRNA encoding nerve growth factor and its receptor in rat sciatic nerve during development, degeneration, and regeneration; role of macrophages. Proc Natl Acad Sci USA84: 8735–8739.
28.
28 Heumann R, Korsching S, Bandtlow C, Thoenen H. (1987) Changes of nerve growth factor synthesis in nonneuronal cells in response to sciatic nerve transection. J Cell Biol104: 1623–1631.
29.
29 Lindholm D, Heumann R, Meyer M, Thoenen H. (1987) Interleukin-1 regulates synthesis of nerve growth factor in non-neuronal cells of rat sciatic nerve. Nature330: 658–659.
30.
30 Lisak RP, Bealmear B. (1991) Antibodies to interleukin-1 inhibit cytokine-induced proliferation of neonatal rat Schwann cells in vitro. J Neuroimmunol31: 123–132.
31.
31 Davis JB, Stroobant P. (1990) Platelet-derived growth factors and fibroblast growth factors are mitogens for rat Schwann cells. J Cell Biol110: 1353–1360.
32.
32 Dower SK, Sims JE, Ceretti DP, Bird TA. (1992) The interleukin-1 system: receptors, ligands and signals. In: Kishimoto T (ed.) Interleukins: Molecular Biology and Immunology.Chem Immunol Karger: Basel, vol 51 pp 33–64.
33.
33 Leutwyler C, Schalch L, Jungi TW. (1993) Evidence for interleukin-1β being a necessary but not sufficient co-stimulatory signal in monocyte-dependent anti-CD3-mediated T-cell triggering. Immunol Lett38: 33–39.
34.
34 Lowenthal JW, Cerottini J-C, MacDonald HR. (1986) Interleukin 1-dependent induction of both interleukin 2 secretion and interleukin 2 receptor expression by thymoma cells. J Immunol137: 1226–1231.
35.
35 Lisak RP, Bealmear B, Ragheb S. (1994) Interleukin-1α, but not interleukin-1β, is a co-mitogen for neonatal rat Schwann cells in vitro and acts via interleukin-1 receptors. J Neuroimmunol55: 171–177.
36.
36 Knott I et al. (1993) Differential effects of interleukin-1α and β on the arachidonic acid cascade in human synovial cells and chondrocytes in culture. Agents Act39: 126–131.
37.
37 Arend WP. (1991) Interleukin 1 receptor antagonist: a new member of the interleukin 1 family. J Clin Invest88: 1445–1451.
38.
38 Dinarello CA, Thompson RC. (1991) Blocking IL-1: interleukin 1 receptor antagonist in vivo and in vitro. Immunol Today12: 404–414.
39.
39 Guenard V, Dinarello CA, Weston PJ, Aebischer P. (1991) Peripheral nerve regeneration is impeded by interleukin-1 receptor antagonist released from a polymeric guidance channel. J Neurosci Res29: 396–400.
40.
40 Ip YN et al. (1992) CNTF and LIF act on neuronal cells via a shared signaling pathway that involves the IL-6 signal transducing receptor component gp130. Cell69: 1121–1132.
41.
41 Lisak RP, Bealmear B. (1994) Antibodies to interleukin-6 inhibit Schwann cell proliferation induced by unfractionated cytokines. J Neuroimmunol50: 127–132.
42.
42 Lisak RP, Bealmear B. (1995) Transforming growth factor-β (TGF-β) is co-mitogenic for Schwann cells (SC) with interleukin-1α (IL-1α). Neurology45 (Suppl 4): A164–165.
43.
43 Moses HL, Yang EY, Pietenpol JA. (1990) TGF-β stimulation and inhibition of cell proliferation: New mechanisms and insights. Cell63: 245–247.
44.
44 Sporn MB, Roberts AB. (1992) Transforming growth factor-β: Recent progress and new challenges. J Cell Biol119: 1017–1021.
45.
45 McCartney-Francis NL, Wahl SM. (1994) Transforming growth factor β: a matter of life and death. J Leuk Biol55: 401–409.
46.
46 Alexandrow MG, Moses HL. (1995) Transforming growth factor β and cell cycle regulation. Cancer Res55: 1452–1457.
47.
47 Eccleston PA, Jessen KR, Mirsky R. (1989) Transforming growth factor-β and γ-interferon have dual effects on growth of peripheral glia. J Neurosci Res24: 534–530.
48.
48 Ridley AJ, Davis JB, Stroobant P, Land H. (1989) Transforming growth factors β1 and β2 are mitogens for rat Schwann cells. J Cell Biol109: 3419–3424.
49.
49 Schubert D. (1992) Synergistic interactions between transforming growth factor beta and fibroblast growth factor regulate Schwann cell mitosis. J Neurobiol23: 143–148.
50.
50 Einheber S et al. (1995) Transforming growth factor-β1 regulates axon/Schwann cell interactions. J Cell Biol129: 443–458.
51.
51 Lisak RP et al. (1996) Transforming growth factor-β (TGF-β) has a different effect on proliferation of neonatal central (CNS) and peripheral (PNS) macroglia in vitro. Neurology40 (Suppl): A190.
52.
52 Karpus WJ, Swanborg RH. (1991) CD4+ suppressor cells inhibit the function of effector cells of experimental autoimmune encephalomyelitis through a mechanism involving transforming growth factor-beta. J Immunol146: 1163–1168.
53.
53 Racke MK et al. (1991) Prevention and treatment of chronic relapsing experimental allergic encephalomyelitis by transforming growth factor-β1. J Immunol146: 3012–3017.
54.
54 Miller A et al. (1992) Suppressor T cells generated by oral tolerization to myelin basic protein suppress both in vitro and in vivo immune responses by the release of transforming growth factor β after antigen specific triggering. Proc Natl Acad Sci USA89: 421–425.
55.
55 Stevens DB, Gould K, Swanborg RH. (1994) Transforming growth factor-β1 inhibits tumor necrosis factor-α/lymphotoxin production and adoptive transfer of disease by effector cells of autoimmune encephalomyelitis. J Neuroimmunol51: 77–83.
56.
56 Raine CS et al. (1990) Adhesion molecules on endothelial cells in the central nervous system: an emerging area in the neuroimmunology of multiple sclerosis. Clin Immunol Immunopathol57: 173–187.
57.
57 Washington R et al. (1994) Expression of immunologically relevant endothelial cell activation antigens on isolated CNS microvessels from patients with MS. Evidence for focal activation of vascular endothelium. Ann Neurol35: 89–97.
59 Bergsteinsdottir K, Kingston A, Mirsky R, Jessen KR. (1991) Rat Schwann cells produce interleukin-1. J Neuroimmunol34: 15–23.
60.
60 Bolin LM et al. (1995) Interleukin-6 production by Schwann cells and induction in sciatic nerve injury. J Neurochem64: 850–858.
61.
61 Skundric DS, Bealmear B, Lisak RP. (1994) IL-1 gene expression in cultured rat Schwann cells (SC). J Neuroimmunol54: 190.
62.
62 Skundric DS, Bealmear B, Lisak RP. (1995) Inducible IL-1α, IL-1β, IL-1R and IL-1 receptor antagonist (RA) expression in cultured rat Schwann cells (SC). J Neurochem64 (Suppl): S69.
63.
63 Skundric DS, Bealmear B, Lisak RP. (1996) Inducible coexpression of IL-1, IL-6 and TNF-α genes in Schwann cells (SC). J Neurochem66 (Suppl 1): S48B.
64.
64 Lisak RP et al. (1983) Cultured human and rat oligodendrocytes and rat Schwann cells do not have immune response gene associated antigen (1a) on their surface. Brain Res289: 285–292.
65.
65 Wekerle H, Schwab M, Linington C, Meyermann R. (1986) Antigen presentation in the peripheral nervous system: Schwann cells present endogenous myelin autoantigens to lymphocytes. Eur J Immunol16: 1551–1557.
66.
66 Gold R, Toyka KV, Hartung H-P. (1995) Synergistic effect of IFN-γ and TNF-α on expression of immune molecules and antigen presentation by Schwann cells. Cell Immunol165: 65–70.
67.
67 Samuel NM, Jessen KR, Grange JM, Mirsky R. (1987) Gamma interferon, but not Mycobacterium leprae, induces major histocompatibility class II antigens on cultures of rat Schwann cells. J Neurocytol16: 281–287.
68.
68 Armati PJ, Pollard JD, van Reyk D, Gatenby P. (1990) Rat and human Schwann cells in vitro can synthesize and express MHC molecules. Muscle & Nerve13: 106–116.
69.
69 Lisak RP, Bealmear B. (1992) Differences in the capacity of gamma-interferons from different species to induce class I and II major histocompatibility complex antigens on neonatal rat Schwann cell in vitro. Pathobiology60: 322–329.
70.
70 Lisak RP, Bealmear B. (1991) α/β interferon induces class I but not class II major histocompatibility (MHC) antigens on neonatal Schwann cells. Neurology41 (Suppl): 188.
71.
71 Steinhoff U, Kaufmann SHE. (1988) Specific lysis by CD8+ T cells of Schwann cells expressing Mycobacteria leprae antigen. Eur J Immunol18: 969–972.
72.
72 Lisak RP, Bealmear B. (1994) Induction of intracellular adhesion molecule-1 (ICAM-1) on Schwann cells (SC) in vitro. Neurology44 (Suppl 2) A265.
73.
73 Marlin SD, Springer TA. (1987) Purified intercellular adhesion molecule-1 (ICAM-1) is a ligand for lymphocyte function-associated antigen 1 (LFA-1). Cell51: 813–819.
74.
74 Shevak EM. (1989) Accessory molecules. In: Paul WB (ed.) Fundamental Immunology, 2nd Edition, Raven Press: New York pp 413–441.
75.
75 Colman DR. (1991) Functional properties of adhesion molecules in myelin formation. Curr Opinion Neurobiol1: 377–381.
76.
76 Grumet M. (1991) Cell adhesion molecules and their subgroups in the nervous system. Curr Opinion Neurobiol1: 370–376.
77.
77 Berendt AR. (1989) Intercellular adhesion molecule-1 is an endothelial cell adhesion receptor for Plasmodium falciparum. Nature, 341: 57–59.
78.
78 Fox G et al. (1989) The cell attachment site on foot-and-mouth disease virus includes the amino acid sequence RGD (arginine-glycine-aspartic acid). Gen Virol70: 625–637.
79.
79 Isberg RR, Leong JM. (1990) Multiple β1 Chain integrals are receptors for invasin, a protein that promotes bacterial penetration into mammalian cells. Cell60: 861–871.
80.
80 Olsson T, Holmdahl R, Klareskog L, Forsum U. (1983) Ia-expression cells and T lymphocytes of different subsets in peripheral nerve tissue during experimental allergic neuritis in Lewis rats. Scand J Immunol18: 339–343.
81.
81 Cadoni Z, Zicca A, Mancardi GL. (1986) Schwann cell expression of HLA-DR antigen in peripheral neuropathies. (letter)Lancetii: 1282–1283.
82.
82 Pollard JD et al. (1986) Class II antigen expression and T lymphocyte subsets in chronic inflammatory demyelinating polyneuropathy. J Neuroimmunol13: 123–134.
83.
83 Hughes RAC, Atkinson PF, Gray IA, Taylor WA. (1987) Major histocompatibility antigens and lymphocyte subsets during allergic neuritis in the Lewis rat. J Neurol234: 390–395.
84.
84 Ota K, Irie H, Takhashi K. (1987) Ia-positive cells in the sciatic nerve during the course of experimental allergic neuritis, J Neuroimmunol13: 283–292.
85.
85 Pollard JD, Baverstock J, McLeod JG. (1987) Class II antigen expression and inflammatory cells in the Guillain-Barre syndrome. Ann Neurol21: 337–341.
86.
86 Mancardi GL et al. (1988) HLA-DR Schwann cell reactivity in peripheral neuropathies of different origin. Neurology38: 848–851.
87.
87 Griffin JW et al. (1990) Macrophage responses in inflammatory neuropathies. Ann Neurol27 (Suppl): S64–S68.
88.
88 Schmidt B et al. (1990) Macrophages but not Schwann cells express Ia antigen in experimental autoimmune neuritis. Ann Neurol28: 70–77.
89.
89 Cowley SA et al. (1989) An immunoelectronmicroscopic study of the expression of major histocompatibility complex (MHC) class II antigens in guinea pig sciatic nerves following induction of intraneural mycobacterial granulomas. J Neuroimmunol23: 223–231.
90.
90 Scarpini E et al. (1990) Quantitative assessment of class II molecules on normal and pathological nerves: Immunocytochemical studies in vivo and in tissue culture. Brain113: 659–675.
91.
91 Yu LT et al. (1990) Expression of major histocompatibility antigens in inflammatory peripheral nerve lesions. J Neuroimmunol30: 121–128.
92.
92 Stoll G et al. (1993) Macrophages and endothelial cells express intercellular adhesion molecule-1 in immune-mediated demyelination but not in Wallerian degeneration of the rat peripheral nervous system. Lab Invest68: 637–644.
